Back

SHASTA-3/4 12-Month Results

30 August 2026 (17:30 - 17:40)
Organised by: Logo
Congress Presentation Part of: HOT LINE 9 Lipid-Lowering Agents ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Gerald Watts

University of Western Australia, Perth (Australia)

11 More presentations in this session

Presentation thumbnail
Discussant review - SHASTA-3/4
Professor B. Nordestgaard (Copenhagen, DK)
Slides Video
Presentation thumbnail
Panel discussion - SHASTA-3/4
Presentation thumbnail
CRHCP: Long-Term Blood Pressure Control and Dementia Risk
Doctor S. Zhong (Shenyang, CN)
Slides Video
Presentation thumbnail
Discussant review - CRHCP: Long-Term Blood Pressure Control and Dementia Risk
Professor T. Guzik (Edinburgh, GB)
Slides Video
Presentation thumbnail
Panel discussion - CRHCP: Long-Term Blood Pressure Control and Dementia Risk

Access the full session

Session thumbnail
HOT LINE 9
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 17:30 CET
You may be interested in
thumbnail
Congress Presentation
Rationale and design of the SHASTA-3 and SHASTA-4 studies: randomized, double-blind, placebo-controlled, phase 3 studies of plozasiran in patients with severe hypertriglyceridemia
30 August 2024
thumbnail
Congress Session
Late-Breaking Science: devices
9 April 2024
thumbnail
Congress Presentation
Multi-centre clinical outcomes of a no-implant interatrial shunt for heart failure with preserved and reduced ejection fraction: update from the ALLEVIATE-HF program
20 May 2023
thumbnail
Congress Presentation
Add-on treatment with zilebesiran for inadequately controlled hypertension: KARDIA-2 RCT
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources